The Significance of Scirrhous Gastric Cancer Cell Lines: the Molecular Characterization Using Cell Lines and Mouse Models

Overview

Journal Hum Cell

Publisher Springer

Specialty Cell Biology

Date 2018 Jun 8

PMID 29876827

Citations 7

Authors

Masakazu Yashiro

Tasuku Matsuoka

Masaichi Ohira

Affiliations

Soon will be listed here.

Abstract

Scirrhous gastric cancer (SGC) exhibits aggressiveness of the rapid infiltrating tumor cells with abundant fibroblasts. Experimental studies using SGC cell lines have obtained useful information about this cancer. Our literature search divulged a total of 18 SGC cell lines; two cell lines were established from primary SGC and the other lines were established from a metastatic lesion of SGC. Fibroblast growth factor receptor 2 (FGFR2) and transforming growth factor-beta receptor (TβR) are linked to the rapid development of SGC. Cross-talk between the cancer cells and cancer-associated fibroblasts (CAFs) has been shown to contribute to the progression of SGC. Chemokine (C-X-C motif) receptor 1 (CXCR1) from SGC cells might be associated with the abundant CAFs in cancer microenvironments. The in vivo models established using SGC cell lines are expected to serve as a useful tool for the development of drugs such as FGFR2 inhibitors, TβR inhibitors, and CXCR1 inhibitors, which might be promising as SGC treatments. However, the number of available SGC cell lines is insufficient for the clarification of the entire biologic behavior of SGC. Since the mechanisms responsible for the characteristic aggressiveness of SGC are not fully elucidated, the establishment of new SGC cell lines could help clarify the biological behavior of SGC and contribute to its treatment.

Citing Articles

Integrated single-cell and bulk RNA sequencing analysis identifies a cancer-associated fibroblast-related gene signature for predicting survival and therapy in gastric cancer.

Zhou Z, Guo S, Lai S, Wang T, Du Y, Deng J BMC Cancer. 2023; 23(1):108.

PMID: 36717783 PMC: 9887891. DOI: 10.1186/s12885-022-10332-w.

The Role of Propolis as a Natural Product with Potential Gastric Cancer Treatment Properties: A Systematic Review.

Rivera-Yanez N, Ruiz-Hurtado P, Rivera-Yanez C, Arciniega-Martinez I, Yepez-Ortega M, Mendoza-Arroyo B Foods. 2023; 12(2).

PMID: 36673507 PMC: 9858610. DOI: 10.3390/foods12020415.

Multi-omic profiling of peritoneal metastases in gastric cancer identifies molecular subtypes and therapeutic vulnerabilities.

Tanaka Y, Chiwaki F, Kojima S, Kawazu M, Komatsu M, Ueno T Nat Cancer. 2022; 2(9):962-977.

PMID: 35121863 DOI: 10.1038/s43018-021-00240-6.

Cancer-Associated Fibroblast-Induced Resistance to Chemotherapy and Radiotherapy in Gastrointestinal Cancers.

Ham I, Lee D, Hur H Cancers (Basel). 2021; 13(5).

PMID: 33803229 PMC: 7963167. DOI: 10.3390/cancers13051172.

Clinical difference between fibroblast growth factor receptor 2 subclass, type IIIb and type IIIc, in gastric cancer.

Yashiro M, Kuroda K, Masuda G, Okuno T, Miki Y, Yamamoto Y Sci Rep. 2021; 11(1):4698.

PMID: 33633310 PMC: 7907198. DOI: 10.1038/s41598-021-84107-x.

References

MURAHASHI K, Yashiro M, Takenaka C, Matsuoka T, Ohira M, Chung K . Establishment of a new scirrhous gastric cancer cell line with loss of heterozygosity at E-cadherin locus. Int J Oncol. 2001; 19(5):1029-33. DOI: 10.3892/ijo.19.5.1029. View

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

Kaizaki R, Yashiro M, Shinto O, Yasuda K, Matsuzaki T, Sawada T . Expression of ERas oncogene in gastric carcinoma. Anticancer Res. 2009; 29(6):2189-93. View

Kuramitsu Y, Baron B, Yoshino S, Zhang X, Tanaka T, Yashiro M . Proteomic differential display analysis shows up-regulation of 14-3-3 sigma protein in human scirrhous-type gastric carcinoma cells. Anticancer Res. 2010; 30(11):4459-65. View

Naito Y, Sakamoto N, Oue N, Yashiro M, Sentani K, Yanagihara K . MicroRNA-143 regulates collagen type III expression in stromal fibroblasts of scirrhous type gastric cancer. Cancer Sci. 2013; 105(2):228-35. PMC: 4317817. DOI: 10.1111/cas.12329. View

Yamaguchi H, Yoshida N, Takanashi M, Ito Y, Fukami K, Yanagihara K . Stromal fibroblasts mediate extracellular matrix remodeling and invasion of scirrhous gastric carcinoma cells. PLoS One. 2014; 9(1):e85485. PMC: 3888433. DOI: 10.1371/journal.pone.0085485. View

Shan X, Wen W, Zhu D, Yan T, Cheng W, Huang Z . miR 1296-5p Inhibits the Migration and Invasion of Gastric Cancer Cells by Repressing ERBB2 Expression. PLoS One. 2017; 12(1):e0170298. PMC: 5242522. DOI: 10.1371/journal.pone.0170298. View

Takahashi K, Mitsui K, Yamanaka S . Role of ERas in promoting tumour-like properties in mouse embryonic stem cells. Nature. 2003; 423(6939):541-5. DOI: 10.1038/nature01646. View

Yanagihara K, Kamada N, Tsumuraya M, AMANO F . Establishment and characterization of a human gastric scirrhous carcinoma cell line in serum-free chemically defined medium. Int J Cancer. 1993; 54(2):200-7. DOI: 10.1002/ijc.2910540207. View

10.

Nozue M, Nishida M, Todoroki T, Iwasaki Y . [Establishment and characterization of a human scirrhus type gastric cancer cell line, GCIY, producing CA19-9]. Hum Cell. 1991; 4(1):71-5. View

11.

Arimura A, Nakamura Y, Shimizu A, Harada M, Yanoma S . [Establishment and characterization of a CA19-9 producing human gastric cancer cell line, STKM-1]. Hum Cell. 1991; 4(1):67-70. View

12.

Kubo T . [Establishment and characterization of a new gastric cancer cell line (OCUM-1), derived from Borrmann type IV tumor]. Nihon Geka Gakkai Zasshi. 1991; 92(10):1451-60. View

13.

Liu Y, Shen D, Yin X, Gavine P, Zhang T, Su X . HER2, MET and FGFR2 oncogenic driver alterations define distinct molecular segments for targeted therapies in gastric carcinoma. Br J Cancer. 2014; 110(5):1169-78. PMC: 3950883. DOI: 10.1038/bjc.2014.61. View

14.

Sekiguchi M, Sakakibara K, Fujii G . Establishment of cultured cell lines derived from a human gastric carcinoma. Jpn J Exp Med. 1978; 48(1):61-8. View

15.

Kuniyasu H, Yasui W, Kitadai Y, Yokozaki H, Ito H, Tahara E . Frequent amplification of the c-met gene in scirrhous type stomach cancer. Biochem Biophys Res Commun. 1992; 189(1):227-32. DOI: 10.1016/0006-291x(92)91548-5. View

16.

Kobayashi M, Iwamatsu A, Shinohara-Kanda A, Ihara S, Fukui Y . Activation of ErbB3-PI3-kinase pathway is correlated with malignant phenotypes of adenocarcinomas. Oncogene. 2003; 22(9):1294-301. DOI: 10.1038/sj.onc.1206256. View

17.

Hasegawa T, Yashiro M, Nishii T, Matsuoka J, Fuyuhiro Y, Morisaki T . Cancer-associated fibroblasts might sustain the stemness of scirrhous gastric cancer cells via transforming growth factor-β signaling. Int J Cancer. 2013; 134(8):1785-95. DOI: 10.1002/ijc.28520. View

18.

Wu L, Zhu Y . The function and mechanisms of action of LOXL2 in cancer (Review). Int J Mol Med. 2015; 36(5):1200-4. DOI: 10.3892/ijmm.2015.2337. View

19.

Kalluri R, Weinberg R . The basics of epithelial-mesenchymal transition. J Clin Invest. 2009; 119(6):1420-8. PMC: 2689101. DOI: 10.1172/JCI39104. View

20.

Klymkowsky M, Savagner P . Epithelial-mesenchymal transition: a cancer researcher's conceptual friend and foe. Am J Pathol. 2009; 174(5):1588-93. PMC: 2671246. DOI: 10.2353/ajpath.2009.080545. View